Updates from the Great Debates in IBD

08/07/2018

Related Content

Gastroenterology
Gastroenterology
Putting neoplasia risks attributed to immunomodulators and biologics into perspective and what to do if a malignancy develops
08/01/2018
08/01/2018
Lipid & Metabolic
Michael J. Bloch, MD
Lipid & Metabolic
CRS 2015: Therapeutic Advances in Hypercholesterolemia: Examining the Role of PCSK-9 Inhibitors in Addressing Unmet Needs
09/28/2015
Faculty Member Michael J. Bloch, MD, talks about PCSK9 with Co-Chair Edward Shahady, MD, FAAFP, ABCL.
09/28/2015
Gastroenterology
aibd
Gastroenterology
How can we better prevent and treat narcotic dependence in our pediatric IBD patients?
08/15/2018
08/15/2018
Endocrinology
Endocrinology
Targeting the Incretin Pathways in Type 2 Diabetes
05/28/2015
Ralph A. DeFronzo, MD, discusses the utilization of glucagon-like peptide-1 agonists and incorporating evidence-based guidelines into practice when considering the use of incretin-based therapies for type 2...
05/28/2015
Psoriatic Arthritis
Gurjit S. Kaeley
Psoriatic Arthritis
Gurjit S. Kaeley, MD, on Enthesitis in Psoriatic Arthritis
07/14/2019
In this video, Gurjit S. Kaeley, MD, from the University of Florida, discusses the importance of evaluating enthesitis in individuals with psoriatic arthritis, and more.
07/14/2019